Flecainide Acetate — $0 on Listed Strengths
Flecainide Acetate is $0 on listed strengths only. Other strengths are not a blanket $0.
Flecainide Acetate Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 on listed strengths |
| Typical Retail | $73.00 |
$0 on listed strengths: 100mg Tablets (max 180); 50mg Tablets (max 180)
About Flecainide Acetate
Flecainide Acetate is a prescription medication. Ask your doctor if Flecainide Acetate is right for you.
Other strengths and forms of Flecainide
Conditions Treated with Flecainide Acetate
How to Check Flecainide Acetate Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Flecainide Acetate at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
About Flecainide Acetate
Flecainide acetate is a crucial medication for individuals managing certain irregular heart rhythms, helping to restore and maintain a steady beat. Understanding its role and how it works is key to your heart health.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Flecainide Acetate is approved for (FDA label)
In patients without structural heart disease, flecainide is indicated for the prevention of - paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms - paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms. Flecainide is also indicated for the prevention of - documented ventricular arrhythmias, such as sustained ventricular tachycardia ( sustained VT), that in the judgment of the physician, are life-threatening. Use of flecainide for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of flecainide is not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic.
Source: Read the full FDA label on DailyMed. Label effective date: June 11, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Flecainide Acetate (FDA label)
In post-myocardial infarction patients with asymptomatic PVCs and nonsustained ventricular tachycardia, flecainide therapy was found to be associated with a 5.1% rate of death and non-fatal cardiac arrest, compared with a 2.3% rate in a matched placebo group (see WARNINGS ).
Source: FDA prescribing information (DailyMed). Set ID: ee9595d5-08a1-4529-9215-ddc3c7f929c4. SPL document ID: e9e0eab5-efc5-4bac-8d46-0bce60b2fcc5. Label effective date: June 11, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Flecainide Acetate (FDA label)
Flecainide is contraindicated in patients with preexisting second- or third degree AV block, or with right bundle branch block when associated with a left hemiblock (bifascicular block), unless a pacemaker is present to sustain the cardiac rhythm should complete heart block occur. Flecainide is also contraindicated in the presence of cardiogenic shock or known hypersensitivity to the drug.
Source: FDA prescribing information (DailyMed). Set ID: ee9595d5-08a1-4529-9215-ddc3c7f929c4. SPL document ID: e9e0eab5-efc5-4bac-8d46-0bce60b2fcc5. Label effective date: June 11, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.